fphcare.co.nz
Fisher & Paykel Healthcare Limited is a New Zealand-based publicly traded medical device company (NZX: FPH) specializing in heated humidification systems, nasal high-flow therapy devices, CPAP masks, and neonatal respiratory products sold globally to hospitals and homecare patients across 30+ countries.
- Company typePublic
- Founded1970
- HeadquartersAuckland, New Zealand
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What fphcare.co.nz does
Fisher & Paykel Healthcare Limited is a New Zealand-headquartered medical device company listed on the NZX (NZE: FPH), founded in 1971 and operating globally with 5,001-10,000 employees. It designs, manufactures, and markets respiratory care and humidification products for two primary end-markets: hospital acute care (adult respiratory support, neonatal/infant respiratory care, surgical humidification) and homecare (sleep apnea therapy, home humidified high-flow therapy). Its core technology is heated humidification combined with nasal high flow (NHF) delivery, anchored by the proprietary Optiflow NHF platform capable of delivering up to 100% oxygen at flow rates up to 70 L/min, supported by patents and clinical evidence accumulated over more than 50 years.
The product ecosystem is broad and integrated: hospital devices (F&P Airvo 2 and Airvo 3 NHF systems, F&P 850 and F&P 950 humidifiers, SH870 surgical humidification), neonatal devices (Neopuff T-Piece Resuscitator, Bubble CPAP System, Optiflow Junior 2), an extensive hospital and homecare mask portfolio (F&P Nova Nasal, Nova Micro, Evora Full, Brevida, Eson 2, Simplus, Vitera, Pilairo Q, FlexiFit series, Opus 360, Zest, Forma), CPAP hardware (F&P SleepStyle, HC150 humidifier), interfaces and consumables (breathing circuits, chambers, Optiflow+ and 3S cannulas, RT302, AirSpiral tubing), and a software/data layer (InfoSmart, InfoSmart Web, myMask App, myAirvo). Proprietary features include Evaqua technology for reducing condensate in invasive ventilation circuits, MicroPillows cushion, and SwingFit headgear.
The business model is B2B medical device sales: revenue is generated through hardware sales (devices and capital equipment) plus recurring consumables and accessories (breathing circuits, chambers, masks, cannulas) sold through direct field sales to hospitals and a global distributor network across 30+ countries, with localized websites for the US, Canada, UK, France, Germany, Spain, Italy, Australia, New Zealand, Japan, Korea, India, Brazil, and Russia. Pricing is quote-based via healthcare sales representatives and distributors and is not publicly disclosed. Marketing leverages clinical education (F&P Education Hub, Infant Care Learning Center, Micro Moments video series) and thought-leadership partnerships (The Incubator neonatal podcast).
fphcare.co.nz firmographics
Firmographics- Name
- fphcare.co.nz
- Legal name
- Fisher & Paykel Healthcare Limited
- Website
- https://fphcare.co.nz
- Company type
- Public
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Fisher & Paykel Healthcare Limited is a New Zealand-based publicly traded medical device company (NZX: FPH) specializing in heated humidification systems, nasal high-flow therapy devices, CPAP masks, and neonatal respiratory products sold globally to hospitals and homecare patients across 30+ countries.
- Ownership category
- akta.pro rank
fphcare.co.nz industry classification
Industry- Product category
- Respiratory Care Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
- akta.pro secondary industries
- Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where fphcare.co.nz is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices1 record
Markets served
fphcare.co.nz business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of respiratory support devices, humidifiers, nasal high flow systems, CPAP devices, and masks for hospital and homecare use. Products include Airvo systems, F&P 950/850 humidifiers, Optiflow therapy systems, and PAP masks. Revenue generated through direct sales to healthcare institutions and through distributor networks globally.
- Consumables and Accessories: Ongoing sales of disposable products including breathing circuits, chambers, nasal cannula, masks, and accessories for both hospital and homecare therapy systems.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
fphcare.co.nz product offering
Product offeringCore offering
Fisher & Paykel Healthcare designs, manufactures, and markets medical devices for respiratory care, including heated humidification systems, nasal high flow therapy devices (Optiflow, Airvo), CPAP machines, an extensive range of PAP masks, and neonatal/infant respiratory support equipment. Products serve both hospital acute care settings (invasive and noninvasive ventilation, surgical humidification, perianesthesia, NICU) and homecare patients (sleep apnea therapy, home humidified high flow).
Product overview
Fisher & Paykel Healthcare offers a comprehensive portfolio of healthcare technologies for respiratory care spanning hospital and home settings. The product ecosystem centers on nasal high flow therapy systems (Airvo 2, Airvo 3, Optiflow), advanced humidification devices (F&P 850, F&P 950), and a extensive range of CPAP/sleep apnea masks (Nova Nasal, Nova Micro, Evora, Brevida, Eson, Simplus, Vitera, Pilairo, Zest, Forma, FlexiFit series) paired with CPAP devices (SleepStyle) and data management software (InfoSmart, InfoSmart Web, myMask App). Hospital offerings include adult respiratory therapy (invasive and noninvasive ventilation), infant/neonatal care products (Neopuff, Bubble CPAP, Optiflow Junior, neonatal resuscitation equipment), and surgical humidification (SH870). The portfolio is designed to address respiratory support across the care continuum from acute hospital settings to home-based chronic therapy.
Differentiator
Problem solved
Functional benefit
Brands
- Optiflow: Nasal High Flow therapy system for adult respiratory care
- F&P Airvo
- F&P Nova Nasal
- F&P Nova Micro
- F&P 950 System
- F&P SleepStyle
- F&P Solo
- F&P Evora Full
- F&P Eson 2
- F&P Brevida
- F&P Simplus
- F&P Vitera
- Bubble CPAP System
- Neopuff
- Optiflow THRIVE
- myAirvo
- myMask App
- InfoSmart
Products and services
- F&P Airvo 3 System Next-generation Optiflow nasal high flow therapy system with integrated battery for intra-hospital transport, high-pressure oxygen input, and broader flow range. Compatible with wide range of interfaces for adult respiratory support in hospital settings.
- Optiflow NHF System Nasal high flow system delivering up to 100% oxygen at flow rates up to 70 L/min to optimize oxygenation for patients in the perianesthesia environment, including general anesthesia, procedural sedation, and postanesthesia care.
- F&P 850 System
Quantifiable outcome
- Delivers up to 100% oxygen at flow rates up to 70 L/min
- +1 more outcomes
Companies that use fphcare.co.nz
Customer profileSegments3 records
Ideal customer profiles3 records
fphcare.co.nz technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
fphcare.co.nz partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- The IncubatorsupportingFisher & Paykel Healthcare collaborates with The Incubator, a global podcast platform, to share expert-led neonatal care discussions that bring positive change to the industry. This partnership supports thought leadership and clinical education marketing initiatives.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
fphcare.co.nz competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Diversified global medical device incumbent with respiratory, patient monitoring, and hospital capital equipment offerings that intersect F&P's acute-care and homecare segments as part of a much broader portfolio.
- GE HealthCare: Large incumbent providing hospital ICU equipment, anesthesia delivery, and patient monitoring. Competes for hospital capital budgets that fund F&P's NHF, humidification, and ventilation sales.
Emerging players
- Masimo: Specializes in non-invasive patient monitoring (including pulse oximetry and respiration monitoring). Adjacent overlap with F&P's hospital respiratory monitoring and connectivity, particularly in neonatal and ICU settings.
Regional players
- Invacare: Long-standing homecare durable medical equipment provider with overlap in home respiratory therapy distribution. Comparable go-to-market in homecare channels but with broader mobility/O2 product focus rather than humidified NHF specialization.
Direct peers
- Drägerwerk: German medical/safety technology company with strong hospital ventilation, anesthesia gas delivery, and neonatal care portfolios. Overlaps with F&P's Airvo, Optiflow THRIVE, and neonatal respiratory lines.
- ResMed: Global leader in sleep apnea/CPAP devices and masks. Directly competes with FPH's SleepStyle CPAP and Nova/Evora/Brevida mask lines in the OSA homecare market and shares the recurring-consumables revenue model.
- Getinge: Provides ICU/mechanical ventilation, anesthesia, and respiratory support equipment used in the same hospital settings as F&P. Competes for the same hospital formulary and capital-equipment budgets.
- Hamilton Medical: Specialist in mechanical ventilators and intelligent ventilation technologies for ICUs and transport. Direct overlap with F&P's invasive ventilation, NIV, and humidification ecosystem.
- Vyaire Medical: Pure-play respiratory care company offering ventilation, airway management, and respiratory diagnostics. Comparable focus on hospital respiratory workflows and consumables.
- Koninklijke Philips (Respironics): Major CPAP, BiPAP, hospital ventilation, and respiratory耗材 competitor through its Respironics franchise. Competes head-to-head in both homecare sleep apnea and hospital NIV/invasive ventilation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
fphcare.co.nz social profiles
Digital presencefphcare.co.nz financial estimates
Financial estimateRevenue estimate
Valuation estimate
fphcare.co.nz leadership team
Management profileNumber of profiles
Profiles5 records
fphcare.co.nz funding detail
Funding detailFunding overview
Funding rounds5 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
fphcare.co.nz M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about fphcare.co.nz
What does fphcare.co.nz do?
Fisher & Paykel Healthcare designs, manufactures, and markets medical devices for respiratory care, including heated humidification systems, nasal high flow therapy devices (Optiflow, Airvo), CPAP machines, an extensive range of PAP masks, and neonatal/infant respiratory support equipment. Products serve both hospital acute care settings (invasive and noninvasive ventilation, surgical humidification, perianesthesia, NICU) and homecare patients (sleep apnea therapy, home humidified high flow).
Is fphcare.co.nz a public or private company?
fphcare.co.nz is a public company. It is classified as public and is currently operating.
When was fphcare.co.nz founded?
fphcare.co.nz was founded in 1970. It employs 5,001 to 10,000 people.
Where is fphcare.co.nz based?
fphcare.co.nz is headquartered in Auckland, New Zealand, in the Oceania region.
How does fphcare.co.nz make money?
Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are consumables and Accessories.
Who are fphcare.co.nz's main competitors?
Broad incumbents on record are Medtronic and GE HealthCare. Masimo is listed as an emerging player. Invacare is listed as a regional player. Direct peers are Drägerwerk, ResMed, Getinge, Hamilton Medical, Vyaire Medical and Koninklijke Philips (Respironics).
Does fphcare.co.nz have an API?
No public API is recorded for fphcare.co.nz.
What industry is fphcare.co.nz in?
fphcare.co.nz's product category is Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLAHAGAA, Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV). Its NAICS code is 339112 and its SIC code is 3841.